St. Louis Business Journal -- A generic painkiller developed by Covidien’s pharmaceutical subsidiary, Mallinckrodt Inc., has received approval from the U.S. Food and Drug Administration.
St. Louis Business Journal -- A generic painkiller developed by Covidien’s pharmaceutical subsidiary, Mallinckrodt Inc., has received approval from the U.S. Food and Drug Administration.
